Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CHKA | P35790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3335918 | 0.98 | CA12 (0.30) | CA2 | |
| SCHEMBL3334781 | 0.94 | CA12 (0.32) | CA2 | |
| SCHEMBL3335172 | 0.91 | CA1 (0.33) | CA2 | |
| SCHEMBL3336202 | 0.91 | CA1 (0.33) | CA2 | |
| SCHEMBL3333025 | 0.89 | ALDH1A1 (0.32) | CA2 | |
| SCHEMBL3334521 | 0.86 | CA12 (0.32) | CA2 | |
| SCHEMBL3335262 | 0.85 | — | — | |
| SCHEMBL3340036 | 0.85 | — | — | |
| SCHEMBL3333741 | 0.83 | — | — | |
| SCHEMBL3340009 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125762-B1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | SHELL INT RESEARCH (NL) | 2013-12-11 | — | — | EP | disclosed |
| US-8188017-B2 | Organic molybdenum compounds and oil compositions containing the same | SHELL OIL COMPANY (US) | 2012-05-29 | — | — | US | disclosed |
| US-20100144568-A1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | SHELL OIL COMPANY | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144568-A1 | ORGANIC MOLYBDENUM COMPOUNDS AND OIL COMPOSITIONS CONTAINING THE SAME | F12, C5, C9 | CA2 4182/4885CHKA 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.